Hi Nadine,
2 sections does mention the comparative assessment that you are pointing out.
For IVD
Section 2.02 recommends a template developed by MEDEC that has reference to Predicates or Comparative Devices. But this comparison is an optional requirement . So technically you can skip this too.
Section 2.04.05-Ref-Comparison to Similar Section does require you to make a comparison with a similar device .
You might need to check if this is an optional section in the matrix . If yes, you can technically omit the comparison under this section too.
I hope this helps.
Best!
------------------------------
Shilpa Pillai
Naperville IL
United States
------------------------------
Original Message:
Sent: 08-Jul-2020 09:12
From: Nadine Adia
Subject: Health Canada Guidance for licence application for an equivalent of a medical device
Indeed I'm talking about the predicate in the world of FDA.
For example if we have a product class III for Canada plan to be submitted and we know that an other medical device much like ours is already marketed should we build the technical file avoiding clinical data on humans and prove equivalence or should we build a complete technical file?
Thank you for your response.
------------------------------
Nadine Adia
Quebec QC
Canada
Original Message:
Sent: 07-Jul-2020 22:53
From: Karen Zhou
Subject: Health Canada Guidance for licence application for an equivalent of a medical device
If I understand you correctly, Canada does not have the equivalent of what is known as a predicate in the world of FDA. The supporting information will depend on the classification of your device.
------------------------------
Karen Zhou
Original Message:
Sent: 07-Jul-2020 13:12
From: Nadine Adia
Subject: Health Canada Guidance for licence application for an equivalent of a medical device
Dear all,
I want to find on Health Canada website a guidance on licence application for an equivalent of a medical device but i can't find anything.
my concern is on document required. As it's an equivalence do we need to submit a clinical trial or clinical data. I don't think so , but I need your experience feed back.
Thank you for in advance for your reply.
Rgds,
------------------------------
Nadine Adia
Quebec QC
Canada
------------------------------